Filing Details
- Accession Number:
- 0001140361-13-045749
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-11 20:21:21
- Reporting Period:
- 2013-12-09
- Filing Date:
- 2013-12-11
- Accepted Time:
- 2013-12-11 20:21:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1207604 | Alan Lewis | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-09 | 15,000 | $26.49 | 34,300 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-12-09 | 7,500 | $38.59 | 41,800 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-12-09 | 22,500 | $69.91 | 19,300 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-12-09 | 15,000 | $0.00 | 15,000 | $26.49 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-12-09 | 7,500 | $0.00 | 15,000 | $38.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-11-12 | 2021-05-11 | No | 4 | M | Direct |
| 0 | 2008-11-22 | 2018-05-21 | No | 4 | M | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The price actually received ranged from $69.7410 to $70.12. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- This stock option is fully vested, and therefore is currently exercisable for 100% of shares.
- Reflects the number of stock options outstanding after the transaction from this specific sotck option grant.
Billionaire Hedge Funds
